A Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin in Patients With Traumatic Brain Injury

Trial Profile

A Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin in Patients With Traumatic Brain Injury

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Brain extract (Primary)
  • Indications Brain injuries
  • Focus Therapeutic Use
  • Acronyms The CAPTAIN Trial
  • Sponsors EVER Neuro Pharma
  • Most Recent Events

    • 17 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top